A Montreal family is funding a breakthrough in rare cancer research through the MUHC Foundation’s SDR Project [1].
This investment targets rare cancers, which often receive less funding and attention than more common malignancies. By supporting specialized research, the family aims to accelerate the development of treatments for patients with underserved diagnoses.
Jim Hindley and his granddaughter, Shawnea Roberts, are leading the Hindley-Roberts family in their support of Dr. Donald Vinh [1]. The family chose to invest in this specific research through the McGill University Health Centre (MUHC) Foundation [1].
Dr. Vinh leads the research initiative, which focuses on uncovering new insights into rare cancer types [1]. The SDR Project serves as the vehicle for this funding, allowing the family's contributions to directly fuel scientific inquiry in Montreal [1].
The family's decision to fund this work stems from a belief that Dr. Vinh's research could lead to significant breakthroughs for patients suffering from rare cancers [2]. The announcement was made on June 16, 2026 [1].
“A Montreal family is funding a breakthrough in rare cancer research”
Private philanthropic funding through initiatives like the SDR Project allows researchers to pursue high-risk or niche medical studies that may not qualify for traditional large-scale government grants. This partnership between the Hindley-Roberts family and the MUHC Foundation highlights a growing trend of targeted private investment to address gaps in rare disease research.
